Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Evaluating MM-310 in Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03076372
Recruitment Status : Unknown
Verified February 2018 by Merrimack Pharmaceuticals.
Recruitment status was:  Recruiting
First Posted : March 10, 2017
Last Update Posted : February 27, 2018
Sponsor:
Information provided by (Responsible Party):
Merrimack Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2018
Estimated Study Completion Date : December 2018